Ingevity Corp (NGVT)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Net sales | 365,100 | 284,000 | 376,900 | 390,600 |
| Cost of sales | 227,200 | 170,600 | 247,000 | 267,400 |
| Gross profit | 137,900 | 113,400 | 129,900 | 123,200 |
| Goodwill impairment charge | 183,800 | - | - | 349,100 |
| Acquisition-related costs | - | - | -100 | -200 |
| Restructuring and other (income) charges, net | 21,900 | 12,300 | 86,900 | 13,100 |
| Interest expense, net | -18,600 | -19,400 | -23,800 | -23,200 |
| Other (income) expense, net | -4,300 | -4,100 | -111,800 | -23,900 |
| Research and technical expenses | 7,800 | 7,700 | 6,700 | 7,300 |
| Selling, general, and administrative expenses | 44,200 | 43,100 | 38,700 | 41,400 |
| Income (loss) before income taxes | -142,700 | 26,800 | -137,900 | -334,600 |
| Provision (benefit) for income taxes | 3,800 | 6,300 | -30,700 | -50,900 |
| Net income (loss) | -146,500 | 20,500 | -107,200 | -283,700 |
| Basic earnings (loss) per share (usd per share) | -4.02 | 0.56 | -2.95 | -7.81 |
| Diluted earnings (loss) per share (usd per share) | -4.02 | 0.56 | -2.95 | -7.81 |
| Shares - diluted basis (shares) | 36,461,000 | 36,663,000 | 36,345,000 | 36,335,000 |
| Weighted average number of common shares outstanding - basic (shares) | 36,461,000 | 36,382,000 | 36,345,000 | 36,335,000 |